CohBar Inc
CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fi… Read more
CohBar Inc (CWBR) - Total Liabilities
Latest total liabilities as of June 2023: $3.00 Million USD
Based on the latest financial reports, CohBar Inc (CWBR) has total liabilities worth $3.00 Million USD as of June 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
CohBar Inc - Total Liabilities Trend (2011–2022)
This chart illustrates how CohBar Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
CohBar Inc Competitors by Total Liabilities
The table below lists competitors of CohBar Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Capitol Nusantara Indonesia
JK:CANI
|
Indonesia | Rp691.34 Billion |
|
TronicS Microsystems SA
PA:ALTRO
|
France | €17.73 Million |
|
Genix Pharmaceuticals Corporation
OTCQB:GENPF
|
USA | $1.35 Million |
|
Retail Food Group Limited
PINK:RFGPF
|
USA | $155.39 Million |
|
BAINS MER MONAC N
MU:RJ8
|
Germany | €534.38 Million |
|
Australian Pacific Coal Ltd
AU:AQC
|
Australia | AU$159.28 Million |
|
iCoreConnect Inc. Common stock
NASDAQ:ICCT
|
USA | $17.24 Million |
Liability Composition Analysis (2011–2022)
This chart breaks down CohBar Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.32 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CohBar Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CohBar Inc (2011–2022)
The table below shows the annual total liabilities of CohBar Inc from 2011 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-12-31 | $1.03 Million | -38.79% |
| 2021-12-31 | $1.69 Million | -50.64% |
| 2020-12-31 | $3.42 Million | -36.60% |
| 2019-12-31 | $5.40 Million | +6.24% |
| 2018-12-31 | $5.08 Million | +308.14% |
| 2017-12-31 | $1.24 Million | +39.98% |
| 2016-12-31 | $888.92K | +12.85% |
| 2015-12-31 | $787.70K | -12.82% |
| 2014-12-31 | $903.58K | +159.64% |
| 2013-12-31 | $348.01K | +397.15% |
| 2012-12-31 | $70.00K | +600.00% |
| 2011-12-31 | $10.00K | -- |